Enliven Therapeutics
ELVN
#4427
Rank
NZ$4.25 B
Marketcap
NZ$69.93
Share price
-0.07%
Change (1 day)
106.29%
Change (1 year)

Earnings for Enliven Therapeutics (ELVN)

Earnings in 2025 (TTM): -NZ$0.21 Billion

According to Enliven Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enliven Therapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$0.21 Billion14.45%
2024 -NZ$0.18 Billion25.17%
2023 -NZ$0.15 Billion115.33%
2022 -NZ$65.24 Million